Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines

Authors:

Abstract
Oral and gastrointestinal mucositis due to cancer therapies such as high-dose chemotherapy and/or radiation continues to be an important clinical problem. Fortunately, there have been strategic advances over the past decade relative to understanding the molecular basis of the injury, opportunities for development of drugs and devices to prevent or treat the toxicity, and clinical guideline development. The following text addresses this paradigm, with focus on evidence-based guidelines as developed by the Multinational Association of Supportive Care in Cancer (MASCC) in collaboration with the International Society of Oral Oncology (ISOO).

This publication has 22 references indexed in Scilit: